WVE

WAVE LIFE SCIENCES LTD

WVE·Y95308105·US·Common Stock·Healthcare - Biotechnology-Activist

WVE (WAVE LIFE SCIENCES LTD) is held by 134 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($195.6M), BlackRock, Inc. ($102.4M), MAVERICK CAPITAL LTD ($73.7M). Net institutional sentiment: Bullish.

134
Holders
(11 Elite)
$907M
Total Value
73% (135)
Consensus
98 buying - 37 selling
13F: Insider & Congress:
WVESmart Money Verdict
View all
Held by 134 funds
11 elite
Who's Trading
ActivistADAdage Capital Management, L.P.0.5%May 13, 2026
ActivistFMR LLCFMR LLC2.8%May 6, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.17.1%Apr 17, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Buy $6.3MMar 30, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Buy $16.0MMar 27, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Buy $2.2MMar 26, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Buy $30.0MMar 26, 2026
InsiderFCFrancis ChrisSell $229KFeb 26, 2026
InsiderFCFrancis ChrisSell $270KFeb 26, 2026
InsiderFCFrancis ChrisSell $129KJan 2, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
27M(+48.2%)$195.6M2.1%-64.74%
72
Increased
14.1M(+11.6%)$102.4M0.0%-51.42%
33
Increased
10.2M(+9.5%)$73.7M0.8%-11.98%
46
Increased
8.7M(+17.5%)$63.1M0.0%-50.55%
34
Decreased
5.4M(-17.5%)$39.4M0.3%-28.22%
0
Increased
5.3M(+12.1%)$38.6M0.1%-35.46%
33
Decreased
5.2M(-65.7%)$37.6M0.0%-55.19%
0
Increased
4.8M(+18.0%)$35M0.0%-54.99%
34
Increased
3.7M(+22.6%)$26.6M0.0%-17.94%
35
Increased
3.6M(+12.9%)$26M0.0%-32.33%
32
Increased
2.2M(+178.9%)$16M0.0%-57.69%
45
Increased
1.9M(+150.6%)$13.6M0.0%-49.33%
45
New
1.8M$13M0.0%-53.50%
39
New
1.6M$11.7M0.0%-53.50%
39
Increased
1.5M(+65.5%)$10.6M0.0%-55.06%
41
Decreased
1.4M(-51.5%)$10M0.0%-41.15%
0
Increased
1.4M(+232.2%)$9.9M0.0%-46.58%
45
Unchanged
1.4M$9.8M0.1%-44.41%
0
Increased
1.4M(+43.3%)$9.5M0.0%-50.28%
37
Increased
1.2M(+15.1%)$8.6M0.0%-28.31%
32

Showing 1-20 of 144

1 / 8

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used